Cas9-mediated targeting of viral RNA in eukaryotic cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25918406.
- Also identified by DOI 10.1073/pnas.1422340112 and PMC identifier 4434742.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clustered, regularly interspaced, short palindromic repeats-CRISPR associated (CRISPR-Cas) systems are prokaryotic RNA-directed endonuclease machineries that act as an adaptive immune system against foreign genetic elements. Using small CRISPR RNAs that provide specificity, Cas proteins recognize and degrade nucleic acids. Our previous work demonstrated that the Cas9 endonuclease from Francisella novicida (FnCas9) is capable of targeting endogenous bacterial RNA. Here, we show that FnCas9 can be directed by an engineered RNA-targeting guide RNA to target and inhibit a human +ssRNA virus, hepatitis C virus, within eukaryotic cells. This work reveals a versatile and portable RNA-targeting system that can effectively function in eukaryotic cells and be programmed as an antiviral defense.
Medical subject headings
- Bacterial Proteins
- CRISPR-Associated Proteins
- Endonucleases
- Francisella
- RNA, Viral